Emcure Pharmaceuticals Past Earnings Performance
Past criteria checks 2/6
Emcure Pharmaceuticals has been growing earnings at an average annual rate of 11.4%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 13.1% per year. Emcure Pharmaceuticals's return on equity is 13.8%, and it has net margins of 7.8%.
Key information
11.4%
Earnings growth rate
11.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 13.1% |
| Return on equity | 13.8% |
| Net Margin | 7.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Emcure Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 72,561 | 5,673 | 17,011 | 0 |
| 30 Jun 24 | 69,172 | 5,119 | 16,575 | 0 |
| 31 Mar 24 | 66,583 | 4,982 | 16,166 | 0 |
| 31 Dec 23 | 65,361 | 5,493 | 15,300 | 0 |
| 30 Sep 23 | 64,139 | 6,003 | 14,434 | 0 |
| 30 Jun 23 | 61,464 | 5,532 | 13,027 | 0 |
| 31 Mar 23 | 59,858 | 5,320 | 13,261 | 0 |
| 31 Mar 22 | 58,554 | 6,622 | 11,825 | 0 |
| 31 Mar 21 | 50,335 | 5,808 | 10,297 | 0 |
| 31 Mar 20 | 50,486 | 836 | 12,995 | 0 |
| 31 Mar 19 | 47,172 | 1,893 | 12,092 | 0 |
Quality Earnings: 544210 has high quality earnings.
Growing Profit Margin: 544210's current net profit margins (7.8%) are lower than last year (9.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 544210's earnings have grown by 11.4% per year over the past 5 years.
Accelerating Growth: 544210's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 544210 had negative earnings growth (-5.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.5%).
Return on Equity
High ROE: 544210's Return on Equity (13.8%) is considered low.